nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0208	0.0208	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0204	0.0204	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0202	0.0202	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0183	0.0183	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0178	0.0178	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0178	0.0178	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0174	0.0174	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0149	0.0149	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0146	0.0146	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0145	0.0145	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0141	0.0141	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0136	0.0136	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0133	0.0133	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0127	0.0127	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0125	0.0125	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0123	0.0123	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0121	0.0121	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.0116	0.0116	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0115	0.0115	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0114	0.0114	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0111	0.0111	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0109	0.0109	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0108	0.0108	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0106	0.0106	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0104	0.0104	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0101	0.0101	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.01	0.01	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00982	0.00982	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0097	0.0097	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00951	0.00951	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0095	0.0095	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00935	0.00935	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00923	0.00923	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0092	0.0092	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0091	0.0091	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00883	0.00883	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00865	0.00865	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0086	0.0086	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00837	0.00837	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0082	0.0082	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00817	0.00817	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00814	0.00814	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00805	0.00805	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00795	0.00795	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00781	0.00781	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00771	0.00771	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00766	0.00766	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00756	0.00756	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0075	0.0075	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00748	0.00748	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00742	0.00742	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00742	0.00742	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00724	0.00724	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00719	0.00719	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00712	0.00712	CbGpPWpGaD
MACITENTAN—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00703	0.00703	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00703	0.00703	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00703	0.00703	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00696	0.00696	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00681	0.00681	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00681	0.00681	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00669	0.00669	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00661	0.00661	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00659	0.00659	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00655	0.00655	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00651	0.00651	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00616	0.00616	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00613	0.00613	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00603	0.00603	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00582	0.00582	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00576	0.00576	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00549	0.00549	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00548	0.00548	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00537	0.00537	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00535	0.00535	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0052	0.0052	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00518	0.00518	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0051	0.0051	CbGpPWpGaD
MACITENTAN—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00503	0.00503	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00503	0.00503	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00498	0.00498	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00488	0.00488	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00478	0.00478	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00472	0.00472	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00469	0.00469	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00459	0.00459	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00455	0.00455	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00442	0.00442	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00438	0.00438	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00431	0.00431	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00423	0.00423	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00413	0.00413	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00411	0.00411	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00409	0.00409	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00403	0.00403	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00402	0.00402	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00397	0.00397	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00395	0.00395	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00384	0.00384	CbGpPWpGaD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00379	0.00379	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00372	0.00372	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00372	0.00372	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0037	0.0037	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00365	0.00365	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00361	0.00361	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00342	0.00342	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00338	0.00338	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00336	0.00336	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00328	0.00328	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00325	0.00325	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00303	0.00303	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00296	0.00296	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00294	0.00294	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00293	0.00293	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00288	0.00288	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00288	0.00288	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00284	0.00284	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00283	0.00283	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00279	0.00279	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00279	0.00279	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00275	0.00275	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00266	0.00266	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00266	0.00266	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00265	0.00265	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00262	0.00262	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00259	0.00259	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00258	0.00258	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00244	0.00244	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00241	0.00241	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00235	0.00235	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00232	0.00232	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00228	0.00228	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00228	0.00228	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00227	0.00227	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0022	0.0022	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00216	0.00216	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00213	0.00213	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00203	0.00203	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00202	0.00202	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.002	0.002	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.002	0.002	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00191	0.00191	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00186	0.00186	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00175	0.00175	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00162	0.00162	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00157	0.00157	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00154	0.00154	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00153	0.00153	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00142	0.00142	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00122	0.00122	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00121	0.00121	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.0012	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000996	0.000996	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000971	0.000971	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000924	0.000924	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00083	0.00083	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000737	0.000737	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000638	0.000638	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000638	0.000638	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000628	0.000628	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000584	0.000584	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000573	0.000573	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000573	0.000573	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000564	0.000564	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000527	0.000527	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000524	0.000524	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00051	0.00051	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000499	0.000499	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000486	0.000486	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000458	0.000458	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000436	0.000436	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000409	0.000409	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000387	0.000387	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000384	0.000384	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000372	0.000372	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000347	0.000347	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000345	0.000345	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000344	0.000344	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000344	0.000344	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000339	0.000339	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000334	0.000334	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000315	0.000315	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000275	0.000275	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000262	0.000262	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000209	0.000209	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000207	0.000207	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	0.000166	0.000166	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	0.000149	0.000149	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	8.95e-05	8.95e-05	CbGpPWpGaD
